Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Cholangiocarcinoma × saracatinib × Clear all

Sponsor

Conditions

Prostatic Neoplasms 2 Breast Neoplasms 2 Tongue Neoplasms 1 Thymoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Endometrial Stromal 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Melanoma 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Fibrosarcoma 1 Fallopian Tube Neoplasms 1 Dermatofibrosarcoma 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1

Interventions

Gemcitabine 25 Cisplatin 17 pembrolizumab 6 Capecitabine 5 Fluorouracil 4 durvalumab 3 Taxes 3 Oxaliplatin 3 Carboplatin 3 130-nm albumin-bound paclitaxel 3 tremelimumab 2 trametinib 2 pemigatinib 2 ivosidenib 2 infigratinib 2 derazantinib 2 atezolizumab 2 Radiotherapy 2 Radiosurgery 2 Platinum 2 Nivolumab 2 Liver Transplantation 2 Leucovorin 2 Drug Therapy 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 vandetanib 1 tucatinib 1 trifluridine tipiracil drug combination 1 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡